C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China flag China · Delayed Price · Currency is CNY
5.77
-0.09 (-1.54%)
May 28, 2026, 3:04 PM CST

SHE:000950 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
81,87182,05180,25578,18567,65762,354
Other Revenue
396.6396.6307.01212.62171.83166.87
82,26882,44780,56278,39767,82962,521
Revenue Growth (YoY)
0.88%2.34%2.76%15.58%8.49%38.26%
Cost of Revenue
76,51976,61574,64172,16262,03856,817
Gross Profit
5,7495,8335,9216,2355,7915,703
Selling, General & Admin
3,7733,8443,9673,6783,2983,078
Research & Development
0.760.470.320.383.2410.04
Other Operating Expenses
205.83194.22189.22212.55188.63155.73
Operating Expenses
4,6634,7004,6884,2793,6143,526
Operating Income
1,0861,1321,2321,9572,1772,177
Interest Expense
-733.4-758.26-1,138-1,340-1,123-1,106
Interest & Investment Income
511.2476.47488.19393.27355.29347.92
Currency Exchange Gain (Loss)
0.020.02-0.170.180.44-0.1
Other Non Operating Income (Expenses)
-163.83-166.71-41.03-103.03-12.363.66
EBT Excluding Unusual Items
699.96683.82541.54906.961,3971,423
Impairment of Goodwill
-31.88-31.88-40.22-20.48-27.91-10.32
Gain (Loss) on Sale of Investments
-2.25-3.076.9216.162.32126.88
Gain (Loss) on Sale of Assets
4.634.6310.530.7910.053.52
Asset Writedown
6.410.190.01-0.01-0.02-0.35
Other Unusual Items
28.9418.1738.7362.9191.2537.35
Pretax Income
705.81671.86557.51966.331,4721,580
Income Tax Expense
158.62150.53155.72236.04309.5289.61
Earnings From Continuing Operations
547.19521.33401.79730.291,1631,291
Net Income to Company
547.19521.33401.79730.291,1631,291
Minority Interest in Earnings
-114.98-134.61-118.8-105.65-210.72-285.23
Net Income
432.21386.72282.99624.63952.281,005
Net Income to Common
432.21386.72282.99624.63952.281,005
Net Income Growth
41.58%36.65%-54.69%-34.41%-5.29%13.69%
Shares Outstanding (Basic)
1,7371,7581,7691,7351,7311,734
Shares Outstanding (Diluted)
1,7371,7581,7691,7351,7311,734
Shares Change (YoY)
-2.78%-0.62%1.94%0.21%-0.12%0.31%
EPS (Basic)
0.250.220.160.360.550.58
EPS (Diluted)
0.250.220.160.360.550.58
EPS Growth
45.63%37.50%-55.56%-34.54%-5.17%13.73%
Free Cash Flow
-716455.13-437.27264.1317.76-239.38
Free Cash Flow Per Share
-0.410.26-0.250.150.01-0.14
Dividend Per Share
0.0600.0600.0600.0500.0600.105
Dividend Growth
--20.00%-16.67%-42.86%-
Gross Margin
6.99%7.07%7.35%7.95%8.54%9.12%
Operating Margin
1.32%1.37%1.53%2.50%3.21%3.48%
Profit Margin
0.53%0.47%0.35%0.80%1.40%1.61%
Free Cash Flow Margin
-0.87%0.55%-0.54%0.34%0.03%-0.38%
EBITDA
1,3461,3931,4962,2032,4082,346
EBITDA Margin
1.64%1.69%1.86%2.81%3.55%3.75%
D&A For EBITDA
259.6260.38263.52246.87231.17169.06
EBIT
1,0861,1321,2321,9572,1772,177
EBIT Margin
1.32%1.37%1.53%2.50%3.21%3.48%
Effective Tax Rate
22.47%22.41%27.93%24.43%21.02%18.33%
Revenue as Reported
82,26882,44780,56278,39767,82962,521
Advertising Expenses
-6.319.429.5720.3923.49
Source: S&P Global Market Intelligence. Standard template. Financial Sources.